The Managing Partners of Concept Bio
By leveraging over 40 years of combined experience in taking therapies from lab discovery to clinical trials and commercialization, Concept Bio operates with a focus on innovation and rapid scaling. We nurture new ventures through a milestone-driven approach, helping startups not only secure funding but also execute strategic plans and form critical partnerships.
Alan Horsager, PhD
Dr. Alan Horsager is a biotechnology executive, entrepreneur, and company builder with deep expertise in genetic medicines. He holds a PhD in Neuroscience from the University of Southern California and has led multiple biotech companies from inception through commercialization and acquisition.
Alan began his career in academic gene therapy research at USC. He later founded and served as CEO of Episona, where he launched a first-in-class epigenetic screening assay for infertility. Most recently, he was President & CEO of Duet BioTherapeutics, a genetic medicines immuno-oncology company developing therapies for solid tumors. He also held strategic advisory roles at L.E.K. Consulting, supporting oncology-focused biopharma clients.
Alan is currently a founding partner at Concept Bio, a venture studio focused on launching breakthrough biotech companies, and a co-founder of a stealth-stage immuno-oncology company.
Cyrus Arman, PhD MBA
Dr. Cyrus Arman is a biotechnology executive, investor, and company builder with deep expertise in drug development, strategy, and venture creation. He holds a PhD in Neuroscience and an MS in Biomedical Engineering from the University of Southern California and an MBA from UCLA Anderson.
Cyrus began his career in competitive intelligence and strategic advisory at Deallus Consulting and Amgen, where he helped shape global product strategies across multiple therapeutic areas. He later served as Chief Business Officer at Nimble Therapeutics and President of CytoDyn, overseeing clinical, regulatory, and corporate development functions. As a venture partner at Apollo Health Ventures, he supports company formation and early-stage investment in aging and age-related disease.
He is currently Co-Founder of a stealth-stage biotech and a founding partner at Concept Bio, a venture studio focused on launching breakthrough biotech companies at the intersection of unmet medical need and translational science.